(Q48030483)

7 February 2018

title

SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrence (English)

1 reference

7 February 2018

1 reference

4

1 reference

7 February 2018

Claudia Hube-Magg

7

Claudia Hube-Magg

1 reference

7 February 2018

Hans Heinzer

12

Hans Heinzer

1 reference

7 February 2018

Sarah Minner

14

Sarah Minner

1 reference

7 February 2018

Guido Sauter

17

Guido Sauter

1 reference

7 February 2018

Thorsten Schlomm

18

Thorsten Schlomm

1 reference

7 February 2018

Stefan Steurer

6

Stefan Steurer

1 reference

7 February 2018

Waldemar Wilczak

19

Waldemar Wilczak

1 reference

7 February 2018

Martina Kluth

13

Martina Kluth

1 reference

7 February 2018

Maria Christina Tsourlakis

15

Maria Christina Tsourlakis

1 reference

7 February 2018

Jakob R Izbicki

16

Jakob R Izbicki

1 reference

7 February 2018

Katharina Grupp

1

Katharina Grupp

1 reference

7 February 2018

Philipp Weigand

10

Philipp Weigand

1 reference

7 February 2018

Hüseyin Sirma

3

Hüseyin Sirma

1 reference

7 February 2018

Kristina Prien

8

Kristina Prien

1 reference

7 February 2018

author name string

Franz Diebel

2

1 reference

7 February 2018

Karin Breitmeyer

5

1 reference

7 February 2018

Taher Pham

9

1 reference

7 February 2018

Uwe Michl

11

1 reference

7 February 2018

publication date

10 July 2013

1 reference

7 February 2018

published in

The Prostate

1 reference

7 February 2018

volume

73

1 reference

7 February 2018

issue

15

1 reference

7 February 2018

page(s)

1690-1698

1 reference

7 February 2018

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22707

The genomic complexity of primary human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22707

Isolation of a crystalline trypsin inhibitor-anticoagulant protein from pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22707

Hepatitis B and Hepatitis C Virus Replication Upregulates Serine Protease Inhibitor Kazal, Resulting in Cellular Resistance to Serine Protease-Dependent Apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22707

Combined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22707

Expression of pancreatic secretory trypsin inhibitor (PSTI) in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22707

Overexpression of tumour-associated trypsin inhibitor (TATI) enhances tumour growth and is associated with portal vein invasion, early recurrence and a stage-independent prognostic factor of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22707

The role of SPINK1 in ETS rearrangement-negative prostate cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22707

Therapeutic targeting of SPINK1-positive prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22707

A two-step toward personalized therapies for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22707

Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22707

Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22707

ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22707

CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22707

Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22707

High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22707

Integrative genomic profiling of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22707

Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22707

Gene expression profiling predicts clinical outcome of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22707

Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression in ERG-fusion-positive cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22707

Expression of tumor-associated trypsinogens (TAT-1 and TAT-2) in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22707

Biochemistry and clinical role of trypsinogens and pancreatic secretory trypsin inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22707

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22707

Integrative molecular concept modeling of prostate cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22707

Interactions and relationships of PTEN, ERG, SPINK1 and AR in castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22707

Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22707

21 January 2018

Identifiers

DOI

10.1002/PROS.22707

1 reference

7 February 2018

release_7zxxpotkonhp7kyjo6r2ax325m

Fatcat ID

0 references

1 reference

7 February 2018